Shengjie Lin, Chen Sun, Rongkang Li, Chong Lu, Xinji Li, Zhenyu Wen, Zhenjian Ge, Wenkang Chen, Yingqi Li, Hang Li, Yongqing Lai
BACKGROUND: Globally, prostate cancer is the second most common malignancy in males. Serum microRNAs (miRNAs) may function as non-invasive and innovative biomarkers for various cancers. Our study aimed to determine potential miRNAs for prostate cancer screening. METHODS: A three-stage study was accomplished to ascertain crucial miRNAs as markers. In the screening stage, we searched PubMed for aberrantly expressed miRNAs relevant to prostate cancer and selected them as candidate miRNAs...
November 13, 2023: International Journal of Biological Markers